X

Trial Profile

Triferic (Ferric Pyrophosphate Citrate) Administered Orally With Shohl's Solution for the Treatment of Iron-Refractory Iron-Deficiency Anemia

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 03 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ferric pyrophosphate (Primary) ; Citric acid/sodium citrate; Ferrous sulfate
Indications Iron deficiency anaemia
Focus Therapeutic Use
Sponsors Rockwell Medical Technologies

Most Recent Events

17 Aug 2020 Status changed from completed to discontinued.
09 Apr 2018 Status changed from active, no longer recruiting to completed.
26 Sep 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Feb 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com